Login / Signup

Structural insight into selectivity of amylin and calcitonin receptor agonists.

Jianjun CaoMatthew J BelousoffElliot GerrardRadostin DanevMadeleine M FletcherEmma Dal MasoHerman SchreuderKatrin LorenzAndreas EversGarima TiwariMelissa BeseniusZiyu LiRachel M JohnsonDenise WoottenPatrick M Sexton
Published in: Nature chemical biology (2023)
Amylin receptors (AMYRs), heterodimers of the calcitonin receptor (CTR) and one of three receptor activity-modifying proteins, are promising obesity targets. A hallmark of AMYR activation by Amy is the formation of a 'bypass' secondary structural motif (residues S19-P25). This study explored potential tuning of peptide selectivity through modification to residues 19-22, resulting in a selective AMYR agonist, San385, as well as nonselective dual amylin and calcitonin receptor agonists (DACRAs), with San45 being an exemplar. We determined the structure and dynamics of San385-bound AMY 3 R, and San45 bound to AMY 3 R or CTR. San45, via its conjugated lipid at position 21, was anchored at the edge of the receptor bundle, enabling a stable, alternative binding mode when bound to the CTR, in addition to the bypass mode of binding to AMY 3 R. Targeted lipid modification may provide a single intervention strategy for design of long-acting, nonselective, Amy-based DACRAs with potential anti-obesity effects.
Keyphrases